NEBRASKA, March 4 - Media Contacts: Taylor Gage, 402-471-1970 Justin Pinkerman, 402-471-1967 Media Release: Gov. Ricketts, DHHS Leaders Outline the Next Phase of the State’s Coronavirus Vaccination Plan Gov. Ricketts (podium) speaks at this morning’s …
Seasoned Clinical Leader Brings Deep Experience in Drug Development, Including Approval of an Oligonucleotide Therapy in Neuromuscular Disease WALTHAM, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease …
FORT LAUDERDALE, Fla., March 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- The Movie Studio, Inc. (OTC: MVES) (the “Company”) proudly announces the release of Moviesode 1 of the upcoming motion picture “The Last Warhead” (https://vimeo.com/499809261), …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement Summary Company …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement Summary Company …
The fund will help qualified investors reap the benefits of art as an alternative asset, using a timely structure to protect and grow their wealth. WILMINGTON, DELAWARE, USA, March 4, 2021 /EINPresswire.com/ -- Artemundi, a leading art fund manager with …
Portland, OR, March 04, 2021 (GLOBE NEWSWIRE) -- As per the report, the global intake filter media market generated $5.15 billion in 2019, and is projected to reach $6.85 billion by 2027, growing at a CAGR of 4.6% from 2020 to 2027. Drivers, restraints, …
FOSTER CITY, Calif. and HANGZHOU, ZHEJIANG, China, March 04, 2021 (GLOBE NEWSWIRE) -- Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that …
• Epsolay® and Twyneo® PDUFA goal dates set for April 26, 2021 and August 1, 2021 respectively • Top-line generic product revenue of $8.7 million in fiscal 2020 • Signed additional generic product collaboration agreements with Perrigo, bringing the number …
RaySecur™ receives prestigious Prism Award for its MailSecur™ scanner, selected as the top new optics and photonics innovation in security technology for 2021. CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- RaySecur, the new standard in mail security …
– Company on track to present data from Phase 2b ReDUX4 trial with losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in late-2Q 2021 – – On track to report results from Phase 1 trial in healthy adult volunteers with FTX-6058 for sickle cell …
Southfield, MI, March 04, 2021 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE:SUI) (the “Company”), a real estate investment trust (“REIT”) that owns and operates or has an interest in manufactured housing communities, recreational vehicle resorts and …
SHENZHEN, China, March 04, 2021 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading mobile developer service provider in China, today announced that it has entered into a partnership agreement with Segway …
Digital analytics consulting and engineering company expands portfolio with a new line of services geared toward helping clients successfully navigate GA4. OTTAWA, ONTARIO, CANADA, March 4, 2021 /EINPresswire.com/ -- Napkyn Analytics, a leading …
VARStreet achieves a new feat in their product enhancement by making significant improvements in their current product line. BOSTON, MASSACHUSETTS, USA, March 4, 2021 /EINPresswire.com/ -- VARStreet Inc, a SaaS provider serving IT and office supplies …
Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003 - Authorization to start clinical trial in the US granted for rare paediatric bone disease Mont-Saint-Guibert, Mar 4, 2021 (GlobeNewswire) - Novadip …
Silence Therapeutics to Present at the Barclays Global Healthcare Conference 4 March 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short …
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- West Mining Corp. (“West” or the “Company”) (CSE: WEST, OTC: WESMF, FRA: 1HL) is pleased to …
Charlotte, N.C., March 04, 2021 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless …
NX-13 was well tolerated with no reported serious adverse events All primary and secondary endpoints in the Phase 1 study of NX-13 were met Landos expects to initiate a Phase 1b trial of NX-13 in patients with ulcerative colitis (UC) later this year …
02 days 05:45:07
